Testicular cancer treatment late effects
Some side effects of treatment for testicular cancer may take a long time to improve. Some may become permanent, or develop years after treatment.
Some side effects of treatment for testicular cancer, may take a long time to improve. Some side effects may become permanent. These are called long-term effects. Other side effects may develop years after treatment has finished. These are called late effects. You may not have any of these effects or they may range from mild to more severe.
Tell your doctor or nurse if you have any of these effects. They will monitor them and arrange any tests you need.
You may get pins and needles or numbness in their hands and feet after chemotherapy for testicular cancer. Or your hands become cold and your fingers go pale. This is known as Raynaud’s phenomenon. It is triggered by being in a cold environment. Keeping your hands and feet warm can help.
Chemotherapy may also affect the nerves of the hands and feet and cause changes in sensation. This is called peripheral neuropathy. It may be temporary or sometimes permanent.
Some chemotherapy drugs may increase your risk of developing heart or lung problems. If you smoke, try to stop. Other things that can help are:
- regular exercise
- eating healthily
- keeping to a healthy weight.
Below is a sample of the sources used in our testicular cancer information. If you would like more information about the sources we use, please contact us at email@example.com
European Association of Urology. Guidelines on Cancer. 2016. Available from: www.baus.org.uk/_userfiles/pages/files/professionals/sections/oncology/EAU2015-Testicular-Cancer.pdf (accessed August 2018)
European Society for Medical Oncology, eUpdate. Testicular Seminoma and Non-Seminoma Treatment Recommendations. June 2017. Available from: www.esmo.org/Guidelines/Genitourinary-Cancers/Testicular-Seminoma-and-Non-Seminoma/eUpdate-Treatment-Recommendation (accessed August 2018).
Scottish Intercollegiate Guidelines Network, Management of adult testicular germ cell tumours. Available from: www.sign.ac.uk/sign-124-management-of-adult-testicular-germ-cell-tumours.html (accessed August 2018).
UpToDate. Clinical manifestations, diagnosis, and staging of testicular germ cell tumors. January 2018. Available from: www.uptodate.com/contents/clinical-manifestations-diagnosis-and-staging-of-testicular-germ-cell-tumors (accessed August 2018).
This information has been written, revised and edited by Macmillan Cancer Support’s Cancer Information Development team. It has been reviewed by expert medical and health professionals and people living with cancer. It has been approved by Senior Medical Editor, Dr Jim Barber, Consultant Clinical Oncologist.
Our cancer information has been awarded the PIF TICK. Created by the Patient Information Forum, this quality mark shows we meet PIF’s 10 criteria for trustworthy health information.
Content under review
The language we use
We want everyone affected by cancer to feel our information is written for them.
We try to make sure our information is as clear as possible. We use plain English, avoid jargon, explain any medical words, use illustrations to explain text, and make sure important points are highlighted clearly.
We use gender-inclusive language and talk to our readers as ‘you’ so that everyone feels included. Where clinically necessary we use the terms ‘men’ and ‘women’ or ‘male’ and ‘female’. For example, we do so when talking about parts of the body or mentioning statistics or research about who is affected. Our aims are for our information to be as clear and relevant as possible for everyone.
You can read more about how we produce our information here.